Company
Building computational technologies for the future of molecular science.
Spacefield Transformation Technologies Ltd is a UK computational science company developing advanced software platforms for molecular science, drug discovery and scientific research.
Our technologies combine mathematical modelling, scientific computing, computational molecular methods and disciplined software engineering to support molecular research, experimental decision-making and the development of reproducible scientific tools.
SPACEFIELD
Transformation Technologies
Company overview
A computational science company built around research, engineering and scientific evidence.
Spacefield develops computational technologies that connect scientific reasoning to usable software. The company is focused on molecular science, drug discovery research and broader scientific computing, with an emphasis on transparent methods, reproducible workflows and clearly defined scientific boundaries.
Our flagship application, the SFT Molecular Platform, brings together shared molecular representations, endpoint-specific prediction modules, validation context and scientific reporting within one connected computational environment.
Spacefield is being developed as a broader scientific technology company rather than around a single product. The same computational and engineering foundations can support future software platforms, research tools and scientific applications as the company grows.
Mission and vision
Scientific ambition with engineering discipline.
Spacefield exists to advance molecular science through rigorous computational methods, scientific software engineering and reproducible research technologies.
To advance molecular science through rigorous computational methods, scientific software engineering and reproducible research technologies.
We pursue this mission by combining mathematical modelling, scientific computing, computational molecular methods, controlled validation and maintainable software engineering.
To build trusted computational infrastructure that helps researchers move from complex molecular questions to reviewable evidence and better-informed experimental decisions.
Our long-term vision is to develop connected scientific platforms, research interfaces and collaboration-ready software that support molecular discovery while preserving traceability, reproducibility and experimental validation.
What we build
From computational foundations to scientific software platforms.
Spacefield develops connected computational technologies rather than isolated software tools. Our work spans theoretical foundations, molecular representation, endpoint-specific prediction, platform integration and reproducible scientific infrastructure.
01
Computational foundations
Mathematical and computational representations
Formal structures, operators and scientific representations provide the conceptual foundation for later software and modelling work.
02
Molecular representation
SFT-Core and descriptor engines
Shared structure-aware representations and descriptor systems translate molecular information into reproducible computational features.
03
Prediction technologies
Endpoint-specific molecular models
Specialised modules address pKa, logP, solubility, blood–brain barrier permeability, ADMET properties and protein–ligand binding.
04
Integrated platform
The SFT Molecular Platform
The flagship platform combines shared representations, prediction modules, validation context, reporting and reproducibility controls within one environment.
05
Scientific infrastructure
Versioned software and research systems
Release governance, integrity manifests, benchmark records, APIs, SDKs and collaboration-ready workflows support the progression from research code to usable scientific technology.
Company principles
Principles for building trusted scientific technology.
Spacefield's work is guided by principles that connect scientific credibility, engineering quality and responsible development.
Scientific rigour
Claims should be supported by appropriate evidence, validation and clearly stated limitations.
Transparency
Methods, assumptions, model scope and release status should be communicated clearly rather than obscured.
Reproducibility
Important computational results should remain connected to versioned code, configuration, data records and execution artefacts.
Collaboration
Scientific progress is strengthened through clearly defined work with researchers, laboratories, CROs and industry partners.
Responsible innovation
Computational predictions should support scientific decisions without overstating biological, clinical or regulatory conclusions.
Long-term thinking
Research, software and company development should favour durable scientific value over short-term claims or unnecessary complexity.
Leadership
Founder-led development with specialist collaboration.
Spacefield is currently led by Joshua Egbon, Founder and Director, with responsibility spanning scientific direction, computational development and company formation.
The company is at an early founder-led stage. Scientific, technical, legal, commercial and experimental capabilities will expand through specialist advisers, collaborators, contractors and future team members as the platform and research programme mature.
JE
Founder & Director
Joshua Egbon
Engineering lecturer, independent researcher and developer of the SFT research and molecular technology programme.
Computational molecular science
Scientific computing
Mathematical modelling
Software engineering
Governance and responsibility
Governance that matches the standards of the technology.
Company development, research collaboration and future commercial activity should remain aligned with clear scientific, legal, ethical and data-governance boundaries.
Legal identity
Spacefield Transformation Technologies Ltd is registered in England and Wales under Company No. 17368270.
Intellectual property
Proprietary software, model artefacts, documentation and research outputs are managed with appropriate protection and access controls.
Responsible research
Computational predictions are presented as research evidence and not as proof of efficacy, safety or regulatory suitability.
Data responsibility
Datasets and partner information should be used under applicable licences, agreements, privacy requirements and security controls.
Validation discipline
Development, validation and locked testing are kept conceptually separate to reduce misleading performance claims.
Clear communication
Website, research and commercial materials should distinguish present capability, planned development and scientific uncertainty.
Working with Spacefield
Building progress through defined scientific collaboration.
Spacefield welcomes conversations with universities, research institutes, CROs, biotechnology companies, pharmaceutical R&D teams, scientific software organisations and specialist advisers.
Potential work may include independent validation, benchmark studies, target-specific pilot projects, software evaluation, experimental testing, data partnerships and carefully scoped research collaborations.
Looking ahead
From founder-led research to a durable scientific technology company.
The next stage of Spacefield's development is focused on strengthening validation, protecting intellectual property, expanding collaboration and progressing selected technologies toward reliable external use.
Complete integration, reporting, release governance and controlled evaluation across the principal molecular technologies.
Work with suitable research and industry partners to assess reproducibility, usability and scientific value.
Develop appropriate licensing, web access, SDK, API, support and organisation-ready deployment models.
Continue exploring
Explore the technology, platform and research behind Spacefield.
Learn how Spacefield develops computational technologies, explore the SFT Molecular Platform, review the research programme or contact the company regarding collaboration and evaluation.